William D. Bloomer

3.9k citations

142 papers · 3.2k indexed · h-index 32

Impact in

Radiation top 2%
- Advanced Radiotherapy Techniques
Cancer Research top 5%
- Cancer, Hypoxia, and Metabolism
- Breast Cancer Treatment Studies

Papers in

Cancer Research 42
- Cancer, Hypoxia, and Metabolism 29
Radiology, Nuclear Medicine and Imaging 46
- Radiopharmaceutical Chemistry and Applications 23
- Medical Imaging Techniques and Applications 12

Co-authors: Maria V. Papadopoulou S. James Adelstein Samuel Hellmän Howard S. Rosenzweig T. Kinsella Marcel Kaiser Shane R. Wilkinson Yves Boucher
Journals: International Journal of Radiation Oncology*Biology*Physics (16 papers)Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics (5 papers)European Journal of Medicinal Chemistry (5 papers)Radiology (4 papers)Cancer Chemotherapy and Pharmacology (4 papers)
Partner nations: United States Switzerland United Kingdom

In The Last Decade

William D. Bloomer

142 papers receiving 3.0k citations

Peers

Countries citing papers authored by William D. Bloomer

Since Specialization

Citations

This map shows the geographic impact of William D. Bloomer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by William D. Bloomer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites William D. Bloomer more than expected).

Fields of papers citing papers by William D. Bloomer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by William D. Bloomer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by William D. Bloomer. The network helps show where William D. Bloomer may publish in the future.

Co-authorship network

The 25 scholars most cited alongside William D. Bloomer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with William D. Bloomer Line = papers co-authored together William D. Bloomer links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	3-Nitrotriazole-based piperazides as potent antitrypanosomal agents European Journal of Medicinal Chemistry ·Maria V. Papadopoulou, William D. Bloomer, Howard S. Rosenzweig, kimi Nakazawa, Shane R. Wilkinson, Marcel Kaiser	2015	21
2	Discovery of potent nitrotriazole-based antitrypanosomal agents: In vitro and in vivo evaluation Bioorganic & Medicinal Chemistry ·Maria V. Papadopoulou, William D. Bloomer, Howard S. Rosenzweig, kimi Nakazawa, Shane R. Wilkinson, Marcel Kaiser, Eric Chatelain, Jean‐Robert Ioset	2015	37
3	NLCQ-1 and NLCQ-2, two new agents with activity against dormant Mycobacterium tuberculosis International Journal of Antimicrobial Agents ·Maria V. Papadopoulou, William D. Bloomer, Michael McNeil	2007	19
4	Accelerated partial breast irradiation using intensity modulated radiotherapy International Journal of Radiation OncologyBiologyPhysics ·Michael A. LaCombe, James T. McMahon, 依田信彦, William D. Bloomer, Y Sfeir Matthew	2004	4
5	IND-directed, five-day repeat dose toxicity study of NLCQ-1 (NSC 709257) administered with or without Taxol® in Sprague Dawley rats. Cancer Research ·Maria V. Papadopoulou, William D. Bloomer, A Gierer Selina, John G. Page	2004	1
6	Therapeutic advantage from combining 5-fluorouracil with the hypoxia-selective cytotoxin NLCQ-1 in vivo; comparison with tirapazamine Cancer Chemotherapy and Pharmacology ·Maria V. Papadopoulou, Nurliah Ghalib, Ji X, William D. Bloomer	2002	11
7	Schedule-dependent potentiation of chemotherapeutic drugs by the bioreductive compounds NLCQ-1 and tirapazamine against EMT6 tumors in mice Cancer Chemotherapy and Pharmacology ·Mohammed Albarqi, Ming Ji, William D. Bloomer	2001	18
8	Optimizing the use of combined radioimmunotherapy and hypoxic cytotoxin therapy as a function of tumor hypoxia International Journal of Cancer ·Rosalyn D. Blumenthal, Alice P. Taylor, Sanjay Bachu, Espace arts visuels, Paul Hanscom, Maria V. Papadopoulou, William D. Bloomer, David M. Goldenberg	2001	17
9	Point dose variations with time during traditional brachytherapy for cervical carcinoma Medical dosimetry ·Gwendolyn C. King, William D. Bloomer, Shalom Kalnicki, C. Faul, William E. Gooding, E Lauzier, Andrew Wu, A. Elliot, Michel Pereira Pinto, Kristina Gerszten, A.M. Kalend	2000	9
10	Effective atomic numbers of composite materials for total and partial interaction processes for photons, electrons, and protons Medical Physics ·Berryman Aa, K. Parthasaradhi, William D. Bloomer	1997	26
11	Solid phase labeling of monoclonal antibodies with 99mTc using two bifunctional photocleavable reagents Nuclear Medicine and Biology ·美紀松村, William D. Bloomer	1995	2
12	Quality assurance for gamma knife stereotactic radiosurgery International Journal of Radiation OncologyBiologyPhysics ·Ann Maitz, Andrew Wu, L. Dade Lunsford, John C. Flíckinger, Douglas Kondziolka, William D. Bloomer	1995	30
13	CAR volume 44 issue 1 Cover and Front matter The Classical Review ·Kira Eghbal-Azar, Mary Whitby, William D. Bloomer, Abdulhafied Alafai, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown)	1994	1
14	CAR volume 44 issue 2 Front matter The Classical Review ·Guilherme Araújo Marinho Magalhães, Kira Eghbal-Azar, Marina Ritter Schuler, Ravshanbek Nabijonov, Mary Whitby, William D. Bloomer, Abdulhafied Alafai, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown)	1994	1
15	γ‐glutamyltranspeptidase expression regulates the growth‐inhibitory activity of the anti‐tumor prodrug γ‐L‐glutaminyl‐4‐hydroxy‐3‐iodobenzene International Journal of Cancer ·María Soledad Boleas-Aguirre, Rebecca P. Hughey, Nü Wang, Content Systems, William D. Bloomer	1994	13
16	Potentiation of 1‐(2‐Chloroethyl)‐3‐cyclohexyl‐1‐nitrosourea's Toxicity in vitro by Two New Bioreductive Agents Japanese Journal of Cancer Research ·Maria V. Papadopoulou, Orkun TÜFENK, William D. Bloomer	1992	4
17	Radiosensitization and Hypoxic Cell Toxicity of NLA‐1 and NLA‐2, Two New Bioreductive Compounds Japanese Journal of Cancer Research ·Maria V. Papadopoulou, Michael W. Epperly, Donna Shields, William D. Bloomer	1992	10
18	Clinical use of a wing field with transmission block for the treatment of the pelvis including the inguinal node International Journal of Radiation OncologyBiologyPhysics ·A.M. Kalend, 和子柿崎, Andrew Wu, Shalom Kalnicki, Allen G. Meek, William D. Bloomer, Maggie Guo	1990	19
19	Effect of prior radiotherapy on postsurgical wound infection Head & Neck ·Jonas T. Johnson, William D. Bloomer	1989	32
20	Preliminary observations of malignant melanoma therapy using radiolabeled alpha‐methyltyrosine Journal of Surgical Oncology ·William McLaughlin, R Stirbulov, Richard M. Lambrecht, Richard A. Milius, William D. Bloomer	1988	9

About William D. Bloomer

William D. Bloomer is a scholar working on Cancer Research, Radiology, Nuclear Medicine and Imaging, Radiation, Toxicology and Organic Chemistry, having authored 142 papers that have together received 3.2k indexed citations. Recurring topics across this work include Cancer, Hypoxia, and Metabolism (29 papers), Synthesis and Biological Evaluation (23 papers), Radiopharmaceutical Chemistry and Applications (23 papers), Cancer therapeutics and mechanisms (19 papers), Advanced Radiotherapy Techniques (16 papers), Trypanosoma species research and implications (13 papers), Medical Imaging Techniques and Applications (12 papers) and Research on Leishmaniasis Studies (12 papers). The work is most often cited by research in Radiation (409 citations), Cancer Research (597 citations), Radiology, Nuclear Medicine and Imaging (836 citations), Oncology (491 citations) and Obstetrics and Gynecology (134 citations). William D. Bloomer has collaborated with scholars based in United States, Switzerland and United Kingdom. Frequent co-authors include Maria V. Papadopoulou, S. James Adelstein, Samuel Hellmän, Howard S. Rosenzweig, T. Kinsella, Marcel Kaiser, Shane R. Wilkinson, Yves Boucher, William McLaughlin and R K Jain. Their work appears in journals such as International Journal of Radiation Oncology*Biology*Physics, Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics, European Journal of Medicinal Chemistry, Radiology and Cancer Chemotherapy and Pharmacology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact